Search
Close this search box.

STOP IATRO

Start Therapeutic OPtimisation and IATRogenesis prevention in Older People

The STOP-IATRO project, which brings together 6 organizations from 3 European countries, aims to raise awareness among healthcare professionals about the risks of iatrogenesis in older people. Through collective strategies based on WHO recommendations, the project seeks to prevent medical complications that can lead to a loss of autonomy. It focuses on identifying obstacles, developing an inclusive strategy, providing training programs, and carrying out pilot actions to improve the quality of care and prevent the adverse effects of medical treatments.

DescripciĂ³n

The STOP-IATRO project brings together a consortium of 6 organizations from 3 European countries (Spain, France, and Portugal). Its main goal is to raise awareness among healthcare professionals about the risks of iatrogenesis, that is, the adverse effects that may arise from medical care and treatments in older people. Based on WHO recommendations (ICOPE program), the project seeks to adopt collective strategies to prevent medical complications that can lead to the loss of autonomy in the elderly.

The COVID-19 pandemic has particularly affected vulnerable populations, such as the elderly. This has increased barriers to accessing essential healthcare services and has deteriorated the quality of care. Although there are national recommendations for preventing adverse reactions to care or medication, their implementation has significantly decreased since the health crisis. These recommendations, created before the pandemic, no longer take into account the current limitations faced by healthcare professionals.

The STOP-IATRO project is organized around four main axes:

  1. Identifying obstacles and facilitating factors: Understanding why recommendations are not followed and assessing the knowledge of the involved healthcare professionals.
  2. Developing an inclusive territorial strategy: This strategy should bridge the gap between community and hospital settings, including different professionals using innovative methods of collective and social intelligence.
  3. Creating training programs: These programs are intended to train healthcare professionals in preventing iatrogenic dependence.
  4. Implementing pilot actions: These actions, jointly defined with local stakeholders, will be carried out for both healthcare professionals and patients.

With these initiatives, STOP-IATRO aims to improve the quality of care for older people and to prevent risks related to iatrogenesis.

Periodo de programaciĂ³n:2021-2027
Fecha de inicio:01/01/2024
Fecha fin:31/12/2026
Estado: On going
Convocatoria: 1st call
Prioridad:3 - Promoting social cohesion and territorial and demographic balance in Sudoe through social innovation, heritage enhancement and services
Objetivo especĂ­fico:SO 4.5 (...) Access to care /health systems
Coste subvencionable: 1.734.959,60 euros
Ayuda FEDER: 1.301.219,70 euros

Beneficiarios

Principal Beneficiary: Centre Hospitalier Universitaire de Toulouse, PĂ´le Pharmacie

Nombre del beneficiario: Centre Hospitalier Universitaire de Toulouse, PĂ´le Pharmacie

RegiĂ³n: France,Midi-PyrĂ©nĂ©es (Occitanie),TOULOUSE

Persona de contacto: Sophie Mourgues

Email: [email protected]

Web
2 - FundaciĂ³ Salut i Envelliment UAB

Nombre del beneficiario: FundaciĂ³ Salut i Envelliment UAB

RegiĂ³n: España,Cataluña,Barcelona

Persona de contacto: Antoni SALVA

Email: [email protected]

Web
3 - Universidade de Aveiro, Departamento de CiĂªncias MĂ©dicas

Nombre del beneficiario: Universidade de Aveiro, Departamento de CiĂªncias MĂ©dicas

RegiĂ³n: Portugal,Centro,Aveiro

Persona de contacto: Diana Oliveira

Email: [email protected]

Web
4 - Instituto PolitĂ©cnico da Guarda, Escola Superior de SaĂºde, Unidade TĂ©cnico-CientĂ­fica - Tecnologias da SaĂºde

Nombre del beneficiario: Instituto PolitĂ©cnico da Guarda, Escola Superior de SaĂºde, Unidade TĂ©cnico-CientĂ­fica - Tecnologias da SaĂºde

RegiĂ³n: Portugal,Centro,Guarda

Persona de contacto: Cristina Castro

Email: [email protected]

Web
5 - CHU de Limoges , PĂ´le Biologie -Pharmacie

Nombre del beneficiario: CHU de Limoges , PĂ´le Biologie -Pharmacie

RegiĂ³n: France,Midi-PyrĂ©nĂ©es (Occitanie),LIMOGES

Persona de contacto: Aurore LOXQ

Email: [email protected]

Web
6 - Instituto de Biomedicina de MĂ¡laga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)

Nombre del beneficiario: Instituto de Biomedicina de MĂ¡laga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)

RegiĂ³n: España,AndalucĂ­a,MĂ¡laga

Persona de contacto: Aitor Rando

Email: [email protected]

Web